Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Intravenous immunoglobulin (IVIG) preparations used prior to this study.
| IVIG prior to this study†[number (%) of patients] | Total, n = 51 | Patients on 4-week regimen, n = 48 | Patients on 3-week regimen, n = 3 |
|---|---|---|---|
| Flebogamma | 17(33·3%) | 16(33·3%) | 1(33·3%) |
| Intraglobin | 16(31·4%) | 15(31·3%) | 1(33·3%) |
| Sandoglobulin | 9(17·6%) | 9(18·8%) | – |
| Endobulin | 6(11·8%) | 5(10·4%) | 1(33·3%) |
| Octagam | 5(9·8%) | 5(10·4%) | – |
| Endoglobulin | 1(2·0%) | 1(2·1%) | – |
| Gammagard | 1(2·0%) | 1(2·1%) | – |
| IG Vena | 1(2·0%) | 1(2·1%) | – |
Trademarks.
